Hikma Pharmaceuticals (HKMPY) News Today $56.91 0.00 (0.00%) As of 06/3/2025 Add Compare Share Share Headlines Stock AnalysisChartDividendHeadlinesShort InterestBuy This Stock HKMPY Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Fitch upgrades Hikma Pharmaceuticals to ’BBB’ with stable outlookMay 29, 2025 | investing.comBio-Thera Solutions and Hikma Pharmaceuticals announce FDA approval of STARJEMZA® (ustekinumab-hmny) Injection, a biosimilar referencing STELARA® (ustekinumab) InjectionMay 27, 2025 | prnewswire.comBio-Thera Solutions and Hikma Pharmaceuticals Announce FDA Approval of STARJEMZA® (ustekinumab-hmny) Injection, a biosimilar referencing STELARA® (ustekinumab) InjectionMay 27, 2025 | prnewswire.comHikma Pharmaceuticals PLC's (LON:HIK) Intrinsic Value Is Potentially 97% Above Its Share PriceMay 16, 2025 | finance.yahoo.comHikma Pharmaceuticals slips Monday, underperforms marketMay 12, 2025 | marketwatch.comHikma acquires Novugen's FDA-approved ANDA for trametinibApril 17, 2025 | prnewswire.comWith 57% ownership, Hikma Pharmaceuticals PLC (LON:HIK) boasts of strong institutional backingApril 12, 2025 | finance.yahoo.comHikma Pharmaceuticals rallies Wednesday, outperforms marketMarch 19, 2025 | marketwatch.comHikma Pharmaceuticals (HIK) Receives a Buy from Berenberg BankMarch 12, 2025 | markets.businessinsider.comHikma looks to launch generic versions of Novo Nordisk diabetes drugs, FT saysMarch 10, 2025 | markets.businessinsider.comAxsome Therapeutics settles Sunosi patent litigation with HikmaMarch 5, 2025 | markets.businessinsider.comAxsome resolves patent dispute with HikmaMarch 5, 2025 | msn.comHikma Pharmaceuticals Full Year 2024 Earnings: Revenues Beat Expectations, EPS LagsFebruary 28, 2025 | finance.yahoo.comEmergent BioSolutions, Hikma enter partnership for sale of Kloxxado nasal sprayJanuary 14, 2025 | markets.businessinsider.comHikma announces exclusive commercial partnership with Emergent BioSolutions for KLOXXADO® (naloxone HCl) nasal spray 8 mgJanuary 14, 2025 | prnewswire.comHikma Pharmaceuticals PLC's (LON:HIK) Stock Is Going Strong: Have Financials A Role To Play?December 20, 2024 | uk.finance.yahoo.comHikma Pharmaceuticals PLC's (LON:HIK) Intrinsic Value Is Potentially 95% Above Its Share PriceNovember 23, 2024 | finance.yahoo.comHikma Pharmaceuticals PLC ADRNovember 18, 2024 | wsj.comThis FTSE 100 stock looks good to me and I’d consider buying it nowSeptember 30, 2024 | uk.finance.yahoo.comPositive Report for Hikma Pharmaceuticals (HIK) from Berenberg BankSeptember 3, 2024 | markets.businessinsider.comHikma Pharmaceuticals participates in naloxone training event with U.S. Congressman Buddy Carter ahead of National Fentanyl Awareness and Prevention DayAugust 20, 2024 | prnewswire.comKLOXXADO® 8mg Naloxone Nasal Spray Shelf-Life Extended from 24 months to 36 monthsAugust 15, 2024 | prnewswire.comWe Think Hikma Pharmaceuticals' (LON:HIK) Robust Earnings Are ConservativeAugust 15, 2024 | finance.yahoo.comAfter earnings, is the Hikma Pharmaceuticals share price due a bounce?August 8, 2024 | msn.comHikma given shot in the arm by ‘excellent’ double-digit growthAugust 8, 2024 | msn.comHikma Pharmaceuticals Shares Surge on Earnings, Guidance RaiseAugust 8, 2024 | marketwatch.comHikma Pharmaceuticals shares surge on upbeat guidanceAugust 8, 2024 | investing.comWC enters into partnership with Hikma PharmaceuticalsAugust 2, 2024 | wnewsj.comHikma Pharma Extends Recall Of Acetaminophen InjectionJuly 23, 2024 | markets.businessinsider.comHikma Pharmaceuticals rises Monday, outperforms marketJuly 22, 2024 | marketwatch.comHikma Pharmaceuticals rises Wednesday, still underperforms marketJuly 19, 2024 | marketwatch.comHikma Pharmaceuticals rises Friday, outperforms marketJuly 19, 2024 | marketwatch.comWith 52% institutional ownership, Hikma Pharmaceuticals PLC (LON:HIK) is a favorite amongst the big gunsApril 15, 2024 | finance.yahoo.comHikma shares spike after pharma giant’s profit up 30 per centFebruary 22, 2024 | msn.comHikma hosts White House Drug Policy Director Dr. Rahul Gupta at its Columbus, Ohio manufacturing facilityFebruary 21, 2024 | prnewswire.comHikma Pharmaceuticals USA Inc.: Hikma announces US launch of COMBOGESIC IVFebruary 5, 2024 | finanznachrichten.deHikma Pharma Launches Pain Relief Injection COMBOGESIC IV In USFebruary 5, 2024 | markets.businessinsider.comHikma announces US launch of COMBOGESIC® IVFebruary 5, 2024 | finance.yahoo.comActiv Surgical Announces Completion of First International Procedure Using Its ActivSight™ Intelligent LightJanuary 22, 2024 | finance.yahoo.comGuardant Health and Hikma Partner to Offer Cancer Screening and Comprehensive Genomic Profiling Tests in the Middle East and North AfricaJanuary 8, 2024 | finance.yahoo.comHikma Pharmaceuticals PLC's (LON:HIK) institutional investors lost 5.8% over the past week but have profited from longer-term gainsNovember 6, 2023 | finance.yahoo.comSK Biopharm inks license deal with Hikma's Middle East unitAugust 17, 2023 | msn.comHikma Pharmaceuticals outperforms market despite losses on the dayAugust 15, 2023 | marketwatch.comHikma Pharmaceuticals goes ex dividend tomorrowAugust 8, 2023 | msn.comIs It Worth Considering Hikma Pharmaceuticals PLC (LON:HIK) For Its Upcoming Dividend?August 6, 2023 | finance.yahoo.comHikma Trims Full-Year Revenue Guidance After Advair Diskus DelayJune 27, 2023 | thestreet.comHikma exceeds 150 injectable medicines in the US with launch of Dobutamine Injection, USPJune 15, 2023 | finance.yahoo.comFTSE 100: Ocado at risk, IMI in – how London Stock Exchange is set to reshuffle the indexMay 31, 2023 | uk.finance.yahoo.comHikma Pharmaceuticals rises Friday, still underperforms marketMay 5, 2023 | marketwatch.comHikma Pharmaceuticals rises Wednesday, outperforms marketMay 3, 2023 | marketwatch.com Get Hikma Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for HKMPY and its competitors with MarketBeat's FREE daily newsletter. Email Address HKMPY Media Mentions By Week HKMPY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HKMPY News Sentiment▼0.590.86▲Average Medical News Sentiment HKMPY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HKMPY Articles This Week▼10▲HKMPY Articles Average Week Get Hikma Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for HKMPY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies FFNTF News Today ABSCF News Today LBTSF News Today AZFL News Today ERBB News Today AVTBF News Today AVCNF News Today BIOYF News Today CBGL News Today NUGS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:HKMPY) was last updated on 6/4/2025 by MarketBeat.com Staff From Our PartnersAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredJunior Explorer Taps Into TSMC’s $165 Billion Chip CorridorThe chip war is moving underground. As the U.S. ramps up semiconductor production to outpace China, an unex...Capital Trends | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredJune 23 Could Trigger $40 Trillion ShiftJune 23 Could Trigger Huge Breakthrough In Under-the-Radar Tech On June 23, scientists will quietly gather ...Stansberry Research | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredTrump plotting new lockdown?It's listed inside the White House's own documents: Federal Register notice 90 FR 4544 to be exact. And wh...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hikma Pharmaceuticals PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Hikma Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HKMPY Stock Free HKMPY Stock Alerts